Search Thermo Fisher Scientific
Urinary Tract Infection (UTI) Testing Research Solutions
PCR-Based Research Use Only (RUO) Panels for UTI Testing
For Research Use Only. Not for use in diagnostic procedures.
Detect slow-growing or difficult-to-culture uropathogens
Including both bacterial and fungal targets across multiple formats
Targeted panels
Targets: 4–9
Examples: Coagulase-negative staphylococci, Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis, Pseudomonas aeruginosa, Staphylococcus saprophyticus, Candida albicans
Syndromic panels
Targets: 24–56
Examples: Acinetobacter baumannii, Citrobacter freundii, Enterobacter aerogenes, Enterobacter cloacae, Enterococcus faecalis, Enterococcus faecium, Escherichia coli, Klebsiella oxytoca, Klebsiella pneumoniae, Morganella morganii, Proteus mirabilis, Proteus vulgaris, Providencia stuartii, Pseudomonas aeruginosa, Streptococcus agalactiae, Ureaplasma urealyticum, Candida albicans
For Research Use Only. Not for use in diagnostic procedures.
Need help finding the right UTI research testing solution?
Learn more about PCR testing formats like single tube and plates ›
Expand your molecular testing research menu using the PCR instrument you have.
Looking to learn ways you can incorporate UTI testing into your laboratory?
Applied Biosystems TaqMan and TrueMark UTI Research
Urinary tract infections (UTIs) are not only prevalent, but can be recurrent, chronic, and even lethal. Dedicated research using the correct tools for identifying the cause of infection is key to combatting them effectively.
While most common UTIs may be discovered with culture-based methods, the detection of severe, higher-risk UTIs benefits from the added assurance of real-time PCR (qPCR) technology.
PCR, when combined with standard culture methods, allows for a level of sensitivity that can uncover the more dangerous, complicated infections that might otherwise be missed. In addition, because PCR can detect and identify multiple targets, it can reveal the specific pathogens causing the infection and ensure the correct methods are used to combat them. This specificity is a benefit for mitigating all UTIs, especially when choosing an appropriate antibiotic, should one be needed.
Applied Biosystems Urinary Research Panels are real-time PCR panels designed to enable rapid analysis of a wide range of urinary tract microbiota in a scalable, low-cost per sample format in under five hours.
Applied Biosystems TrueMark real-time PCR solution are part of a sample-to-results workflow. Benefits include the ability to:
- Detect and differentiate multiple pathogens
- Obtain reliable real-time PCR results—Accurate, sensitive, and specific
- Select from multiple format options to suit your testing capacity—Choose from single tube assays, 96- or 384-well plates, cards, or OpenArray plates
- Order individual assays, predesigned panels, or customize your own—Select from a catalogue of >600 assays targeting pathogens or resistance genes
- Reduce time-to-implementation—Accelerate and streamline your validation process with Analytical Validation Consulting Services